These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
364 related articles for article (PubMed ID: 38239049)
61. Dental Biofilm Microbiota Dysbiosis Is Associated With the Risk of Acute Graft- Heidrich V; Bruno JS; Knebel FH; de Molla VC; Miranda-Silva W; Asprino PF; Tucunduva L; Rocha V; Novis Y; Arrais-Rodrigues C; Fregnani ER; Camargo AA Front Immunol; 2021; 12():692225. PubMed ID: 34220852 [TBL] [Abstract][Full Text] [Related]
62. Impact of oral microbiota on pathophysiology of GVHD. Yamamoto A; Kambara Y; Fujiwara H Front Immunol; 2023; 14():1132983. PubMed ID: 36969182 [TBL] [Abstract][Full Text] [Related]
63. Gut microbiota intervention by pre and probiotics can induce regulatory T cells and reduce the risk of severe acute GVHD following allogeneic hematopoietic stem cell transplantation. Yazdandoust E; Hajifathali A; Roshandel E; Zarif MN; Pourfathollah AA; Parkhideh S; Mehdizadeh M; Amini-Kafiabad S Transpl Immunol; 2023 Jun; 78():101836. PubMed ID: 37037266 [TBL] [Abstract][Full Text] [Related]
64. Profiling the Fungal Microbiome after Fecal Microbiota Transplantation for Graft-versus-Host Disease: Insights from a Phase 1 Interventional Study. van Lier YF; Rolling T; Armijo GK; Zhai B; Haverkate NJE; Meijer E; Nur E; Blom B; Peled JU; van den Brink MRM; Hohl TM; Hazenberg MD; Markey KA Transplant Cell Ther; 2023 Jan; 29(1):63.e1-63.e5. PubMed ID: 36280104 [TBL] [Abstract][Full Text] [Related]
65. The Impact of Antibiotic-Mediated Modification of the Intestinal Microbiome on Outcomes of Allogeneic Hematopoietic Cell Transplantation: Systematic Review and Meta-Analysis. Gavriilaki M; Sakellari I; Anagnostopoulos A; Gavriilaki E Biol Blood Marrow Transplant; 2020 Sep; 26(9):1738-1746. PubMed ID: 32447043 [TBL] [Abstract][Full Text] [Related]
66. [Fecal microbiota transplantation for graft-versus-host disease in children and adults: methods, clinical effects, safety]. Goloshchapov OV; Chukhlovin AB; Bakin EA; Stanevich OV; Klementeva RV; Shcherbakov AA; Shvetsov AN; Suvorova MA; Bondarenko SN; Kucher MA; Kulagin AD; Zubarovskaya LS; Moiseev IS Ter Arkh; 2020 Sep; 92(7):43-54. PubMed ID: 33346444 [TBL] [Abstract][Full Text] [Related]
67. A gut microbiota score predicting acute graft-versus-host disease following myeloablative allogeneic hematopoietic stem cell transplantation. Han L; Zhao K; Li Y; Han H; Zhou L; Ma P; Fan Z; Sun H; Jin H; Jiang Z; Liu Q; Peng J Am J Transplant; 2020 Apr; 20(4):1014-1027. PubMed ID: 31605563 [TBL] [Abstract][Full Text] [Related]
68. Allogenic stem cell transplant-associated acute graft versus host disease: a computational drug discovery text mining approach using oral and gut microbiome signatures. Beckman MF; Morton DS; Bahrani Mougeot F; Mougeot JC Support Care Cancer; 2021 Apr; 29(4):1765-1779. PubMed ID: 33094358 [TBL] [Abstract][Full Text] [Related]
73. Anaerobic Antibiotics and the Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. Tanaka JS; Young RR; Heston SM; Jenkins K; Spees LP; Sung AD; Corbet K; Thompson JC; Bohannon L; Martin PL; Stokhuyzen A; Vinesett R; Ward DV; Bhattarai SK; Bucci V; Arshad M; Seed PC; Kelly MS Biol Blood Marrow Transplant; 2020 Nov; 26(11):2053-2060. PubMed ID: 32682948 [TBL] [Abstract][Full Text] [Related]
74. Chinese Medicine Treatment on Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. Wu XL; Zhuang HF; Zhao YN; Yu XL; Dai TY; Gao RL Chin J Integr Med; 2020 May; 26(5):324-329. PubMed ID: 32350801 [TBL] [Abstract][Full Text] [Related]
75. A single strain of Bacteroides fragilis protects gut integrity and reduces GVHD. Sofi MH; Wu Y; Ticer T; Schutt S; Bastian D; Choi HJ; Tian L; Mealer C; Liu C; Westwater C; Armeson KE; Alekseyenko AV; Yu XZ JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33554953 [TBL] [Abstract][Full Text] [Related]
76. The Potential Roles of Mucosa-Associated Invariant T Cells in the Pathogenesis of Gut Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation. Gao MG; Hong Y; Zhao XY; Pan XA; Sun YQ; Kong J; Wang ZD; Wang FR; Wang JZ; Yan CH; Wang Y; Huang XJ; Zhao XS Front Immunol; 2021; 12():720354. PubMed ID: 34539656 [TBL] [Abstract][Full Text] [Related]
77. A phase 2 trial of the somatostatin analog pasireotide to prevent GI toxicity and acute GVHD in allogeneic hematopoietic stem cell transplant. Ramalingam S; Siamakpour-Reihani S; Bohannan L; Ren Y; Sibley A; Sheng J; Ma L; Nixon AB; Lyu J; Parker DC; Bain J; Muehlbauer M; Ilkayeva O; Kraus VB; Huebner JL; Spitzer T; Brown J; Peled JU; van den Brink M; Gomes A; Choi T; Gasparetto C; Horwitz M; Long G; Lopez R; Rizzieri D; Sarantopoulos S; Chao N; Sung AD PLoS One; 2021; 16(6):e0252995. PubMed ID: 34170918 [TBL] [Abstract][Full Text] [Related]
78. Update in clinical and mouse microbiota research in allogeneic haematopoietic cell transplantation. Lindner S; Peled JU Curr Opin Hematol; 2020 Nov; 27(6):360-367. PubMed ID: 33003084 [TBL] [Abstract][Full Text] [Related]